Reporter gene assays demonstrated that Tyr88∗-mutant SMAD1 failed to transcriptionally activate the promoters of TBX20 and NKX2.5, two well-established CHD-causing genes [22, 23]. This evidence concerns the gene NKX2-5 and coronary artery disorder.